Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003
In an article that appeared in the "Evidence-Based Dermatology: Research Commentary" section of the ARCHIVES, Dr Williams1 raised several questions concerning an article that reported the results of a study on 1% pimecrolimus cream for the treatment of mild and moderate atopic dermatitis in children and adolescents.2 As the authors of that article, we would like to respond to Dr Williams' comments, because it is our belief that the efficacy of topical pimecrolimus has been evidentially demonstrated.
Eichenfield LF, Lucky AW, Boguniewicz M, Langley RGB, Cherill R, Marshall K. 1% Pimecrolimus Cream for Atopic Dermatitis. Arch Dermatol. 2003;139(10):1369-1370. doi:10.1001/archderm.139.10.1369